Literature DB >> 2450136

Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.

D J Heavey1, P B Ernst, R L Stevens, A D Befus, J Bienenstock, K F Austen.   

Abstract

Mucosal mast cells (MMC) were isolated from the intestine of Nippostrongylus brasiliensis-infected rats and then activated with Ag or with anti-IgE in order to assess their metabolism of arachidonic acid to leukotriene (LT) C4, LTB4, and prostaglandin D2 (PGD2). After challenge of MMC preparations of 19 +/- 1% purity with five worm equivalents of N. brasiliensis Ag, the net formation of immunoreactive equivalents of LTC4, LTB4, and PGD2 was 58 +/- 8.3, 22 +/- 4.5, and 22 +/- 3.4 ng/10(6) mast cells, respectively (mean +/- SE, n = 7). When MMC preparations of 56 +/- 9% purity were activated by Ag, the net generation of immunoreactive equivalents of LTC4, LTB4, and PGD2/10(6) MMC was 107 +/- 15, 17 +/- 5.4, and 35 +/- 18 ng, respectively. These data indicate that the three eicosanoids originated from the MMC rather than from a contaminating cell. Analysis by reverse phase HPLC of the C-6 sulfidopeptide leukotrienes present in the supernatants of the activated MMC preparations of lower purity revealed LTC4, LTD4, and LTE4. In a higher purity MMC preparation only LTC4 was present, suggesting that other cell types in the mucosa are able to metabolize LTC4 to LTD4 and LTE4. The release of histamine and the generation of eicosanoids from intestinal MMC and from peritoneal cavity-derived connective tissue-type mast cells (CTMC) isolated from the same N. brasiliensis-infected rats were compared. When challenged with anti-IgE, these MMC released 165 +/- 41 ng of histamine/10(6) mast cells, and generated 29 +/- 3.6, 12 +/- 4.2, and 4.7 +/- 1.0 ng (mean +/- SE, n = 3) of immunoreactive equivalents of LTC4, LTB4, and PGD2/10(6) mast cells, respectively. In contrast, CTMC isolated from the same animals and activated with the same dose of anti-IgE released approximately 35 times more histamine (5700 +/- 650 ng/10(6) CTMC), generated 7.5 +/- 2.3 ng of PGD2/10(6) mast cells, and failed to release LTC4 or LTB4. These studies establish, that upon immunologic activation, rat MMC and CTMC differ in their quantitative release of histamine and in their metabolism of arachidonic acid to LTC4 and LTB4.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  The mechanism for the contraction induced by leukotriene C4 in guinea-pig taenia coli.

Authors:  S Ieiri; J Nishimura; K Hirano; S Suita; H Kanaide
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4.

Authors:  Ana Lukic; Jie Ji; Helena Idborg; Bengt Samuelsson; Lena Palmberg; Susanne Gabrielsson; Olof Rådmark
Journal:  J Lipid Res       Date:  2016-07-19       Impact factor: 5.922

3.  Natural resistance of W/Wv mice to ethanol-induced gastric lesions and its abrogation by bone marrow grafting: possible role of mast cells and LTC4.

Authors:  A Higa; T Yoshida; K Tanaka; T Abe; Y Nawa
Journal:  Gastroenterol Jpn       Date:  1991-06

4.  Differentiation of mast cells during postnatal development of neonatally estrogen-treated rats.

Authors:  F Gaytan; C Bellido; G Carrera; E Aguilar
Journal:  Cell Tissue Res       Date:  1990-01       Impact factor: 5.249

5.  Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation.

Authors:  M H Perdue; S Masson; B K Wershil; S J Galli
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.

Authors:  C M Hogaboam; D Donigi-Gale; T S Shoupe; E Y Bissonnette; A D Befus; J L Wallace
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

7.  Genetic analysis of IgE.

Authors:  F K Stevenson; R E Snow; C J Chapman; A J Frew; S T Holgate
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

Review 8.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

9.  Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner.

Authors:  Bruno L Diaz; Yoshiyuki Satake; Eriya Kikawada; Barbara Balestrieri; Jonathan P Arm
Journal:  Biochim Biophys Acta       Date:  2006-09-22

10.  Ancient origin of mast cells.

Authors:  G William Wong; Lisheng Zhuo; Koji Kimata; Bing K Lam; Nori Satoh; Richard L Stevens
Journal:  Biochem Biophys Res Commun       Date:  2014-08-02       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.